XML 14 R5.htm IDEA: XBRL DOCUMENT v3.21.2
STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Balance, shares at Sep. 30, 2019   35,231,776    
Balance, amount at Sep. 30, 2019 $ 5,133,667 $ 352,318 $ 358,507,603 $ (353,726,254)
Adoption of new accounting standard 2,146,195     2,146,195
Issuance of common stock, shares   606,395    
Issuance of common stock, amount 5,050,003 $ 6,064 5,043,939 0
Warrant exercises, shares   132,900    
Warrant exercises, amount 297,101 $ 1,329 295,772 0
Equity based compensation - employees 1,800,225 $ 0 1,800,225 0
contributions paid in common stock, shares   4,474    
contributions paid in common stock, amount 40,937 $ 45 40,892 0
Stock issued to nonemployees for service, shares   15,819    
Stock issued to nonemployees for service, amount 84,447 $ 158 84,289 0
Purchase of stock by officer, shares   3,725    
Purchase of stock by officer, amount 25,000 $ 37 24,963 0
Share issuance costs (92,150) 0 (92,150) 0
Net loss (5,531,360) $ 0 0 (5,531,360)
Balance, shares at Dec. 31, 2019   35,995,089    
Balance, amount at Dec. 31, 2019 8,954,065 $ 359,951 365,705,533 (357,111,419)
Balance, shares at Sep. 30, 2019   35,231,776    
Balance, amount at Sep. 30, 2019 5,133,667 $ 352,318 358,507,603 (353,726,254)
Net loss (24,876,157)      
Balance, shares at Jun. 30, 2020   38,522,236    
Balance, amount at Jun. 30, 2020 20,888,291 $ 385,223 396,959,284 (376,456,216)
Balance, shares at Dec. 31, 2019   35,995,089    
Balance, amount at Dec. 31, 2019 8,954,065 $ 359,951 365,705,533 (357,111,419)
Warrant exercises, shares   562,100    
Warrant exercises, amount 4,318,706 $ 5,621 4,313,085 0
Equity based compensation - employees 1,780,979 $ 0 1,780,979 0
contributions paid in common stock, shares   3,376    
contributions paid in common stock, amount 38,959 $ 34 38,925 0
Stock issued to nonemployees for service, shares   17,120    
Stock issued to nonemployees for service, amount 235,024 $ 171 234,853 0
Share issuance costs (199,372) 0 (199,372) 0
Net loss (9,067,818) $ 0 0 (9,067,818)
Proceeds from the sale of common stock, shares   721,459    
Proceeds from the sale of common stock, amount 7,867,629 $ 7,215 7,860,414 0
Purchase of stock by officers and directors, shares   16,787    
Purchase of stock by officers and directors, amount 159,990 $ 168 159,822 0
Option exercises, shares   20,480    
Option exercises, amount 49,898 $ 205 49,693 0
Balance, shares at Mar. 31, 2020   37,336,411    
Balance, amount at Mar. 31, 2020 14,138,060 $ 373,365 379,943,932 (366,179,237)
Warrant exercises, shares   849,845    
Warrant exercises, amount 10,156,275 $ 8,498 10,147,777 0
Equity based compensation - employees 3,109,127 $ 0 3,109,127 0
contributions paid in common stock, shares   2,875    
contributions paid in common stock, amount 42,895 $ 29 42,866 0
Stock issued to nonemployees for service, shares   14,811    
Stock issued to nonemployees for service, amount 205,381 $ 148 205,233 0
Share issuance costs (418,497) 0 (418,497) 0
Net loss (10,276,979) $ 0 0 (10,276,979)
Proceeds from the sale of common stock, shares   94,575    
Proceeds from the sale of common stock, amount 1,074,807 $ 946 1,073,861 0
Option exercises, shares   73,719    
Option exercises, amount 276,415 $ 737 275,678 0
Shares issued for settlement of clinical research costs, shares   150,000    
Shares issued for settlement of clinical research costs, amount 1,769,500 $ 1,500 1,768,000 0
Modification of warrants 5,554 0 5,554 0
Warrant issuances 805,753 $ 0 805,753 0
Balance, shares at Jun. 30, 2020   38,522,236    
Balance, amount at Jun. 30, 2020 20,888,291 $ 385,223 396,959,284 (376,456,216)
Balance, shares at Sep. 30, 2020   38,730,150    
Balance, amount at Sep. 30, 2020 19,726,674 $ 387,302 401,174,675 (381,835,303)
Warrant exercises, shares   15,000    
Warrant exercises, amount 89,250 $ 150 89,100 0
Equity based compensation - employees 3,296,309 $ (20) 3,296,329 0
contributions paid in common stock, shares   3,564    
contributions paid in common stock, amount 41,671 $ 36 41,635 0
Share issuance costs (117,021) 0 (117,021) 0
Net loss (7,936,864) $ 0 0 (7,936,864)
Proceeds from the sale of common stock, shares   1,000,000    
Proceeds from the sale of common stock, amount 13,559,500 $ 10,000 13,549,500 0
Option exercises, shares   5,300    
Option exercises, amount 23,511 $ 53 23,458 0
Modification of warrants 192 $ 0 192 0
Equity based compensation - employees, shares   (2,000)    
Stock and options issued to nonemployees for service, shares   15,044    
Stock and options issued to nonemployees for service, amount 152,450 $ 150 152,300 0
Balance, shares at Dec. 31, 2020   39,767,058    
Balance, amount at Dec. 31, 2020 28,835,672 $ 397,671 418,210,168 (389,772,167)
Balance, shares at Sep. 30, 2020   38,730,150    
Balance, amount at Sep. 30, 2020 19,726,674 $ 387,302 401,174,675 (381,835,303)
Net loss (28,156,252)      
Balance, shares at Jun. 30, 2021   42,963,391    
Balance, amount at Jun. 30, 2021 59,793,744 $ 429,634 469,355,665 (409,991,555)
Balance, shares at Dec. 31, 2020   39,767,058    
Balance, amount at Dec. 31, 2020 28,835,672 $ 397,671 418,210,168 (389,772,167)
Warrant exercises, shares   991,239    
Warrant exercises, amount 7,938,841 $ 9,912 7,928,929 0
Equity based compensation - employees 3,282,742 $ 0 3,282,742 0
contributions paid in common stock, shares   3,347    
contributions paid in common stock, amount 51,420 $ 33 51,387 0
Share issuance costs (13,828) 0 (13,828) 0
Net loss (11,281,120) $ 0 0 (11,281,120)
Option exercises, shares   48,845    
Option exercises, amount 138,788 $ 489 138,299 0
Stock and options issued to nonemployees for service, shares   13,486    
Stock and options issued to nonemployees for service, amount 379,277 $ 135 379,142 0
Balance, shares at Mar. 31, 2021   40,823,975    
Balance, amount at Mar. 31, 2021 29,331,792 $ 408,240 429,976,839 (401,053,287)
Warrant exercises, shares   437,312    
Warrant exercises, amount 1,379,490 $ 4,373 1,375,117 0
Equity based compensation - employees 3,511,359 $ 0 3,511,359 0
contributions paid in common stock, shares   6,111    
contributions paid in common stock, amount 53,205 $ 61 53,144 0
Share issuance costs (103,185) 0 (103,185) 0
Net loss (8,938,268) $ 0 0 (8,938,268)
Proceeds from the sale of common stock, shares   1,610,000    
Proceeds from the sale of common stock, amount 33,803,926 $ 16,100 33,787,826 0
Option exercises, shares   72,809    
Option exercises, amount 464,162 $ 728 463,434 0
Modification of warrants 24,195 $ 0 24,195 0
Stock and options issued to nonemployees for service, shares   13,184    
Stock and options issued to nonemployees for service, amount 267,068 $ 132 266,936 0
Balance, shares at Jun. 30, 2021   42,963,391    
Balance, amount at Jun. 30, 2021 $ 59,793,744 $ 429,634 $ 469,355,665 $ (409,991,555)